Original ResearchFull Report: Clinical—Alimentary TractRamosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women
Full Report: Clinical—Alimentary Tract
Under a Creative Commons license
open access
Keywords
5-Hydroxytryptamine-3–Receptor Antagonist
Abdominal Pain
Discomfort
5-HT
Abbreviations used in this paper
BSFS
Bristol Stool Form Scale
CI
confidence interval
FDA
Food and Drug Administration
5-HT
5-hydroxytryptamine
5-HT3
5-hydroxytryptamine receptor 3
IBS
irritable bowel syndrome
IBS-D
irritable bowel syndrome with diarrhea
MCID
minimal clinically important difference
NNH
number needed to harm
NNT
number needed to treat
QOL
quality of life
RR
relative risk
Cited by (0)
Conflicts of interest The authors disclose the following: Shin Fukudo, Yoshikazu Kinoshita, Toshikatsu Okumura, and Ken Haruma are medical consultants contracted to Astellas Pharma, Inc; and Motoko Ida, Hikaru Akiho, Yoshihiro Nakashima, and Akito Nishida are employees of Astellas Pharma, Inc.
Funding Supported by Astellas Pharma, Inc (Tokyo, Japan).
Author names in bold designate shared co-first authorship.